News & Press Releases

Access the latest news about Lipidor, our current projects, publications and collaborations. Thank you for your interest in Lipidor!

Subscribe

May 25, 2025

Lipidor applies for bankruptcy

STOCKHOLM, Sweden, 25th May 2025 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announces today that the Company's board has resolved to file for bankruptcy on behalf of the Company. The bankruptcy application will be submitted today, 25th May 2025, to the Stockholm District Court. The decision was…

January 18, 2021

Lipidor and Cannassure enter exclusive licensing agreement regarding topical medical cannabis products based on Lipidor’s AKVANO[®] technology

STOCKHOLM, Sweden, 18 January 2021 – Lipidor AB (Nasdaq First North:LIPI) today announced that the Company has signed an exclusive licensing agreement…

December 16, 2020

Lipidor signs cooperation agreement with contract manufacturer to offer licensees the opportunity for GMP production

STOCKHOLM, Sweden, 16 December 2020 – Lipidor AB (Nasdaq First North:LIPI) announced today that the Company has signed a new cooperation agreement…

November 27, 2020

Lipidor presents Nomination Committee

Stockholm, 27 November 2020 – Lipidor’s Annual General Meeting on 11[th] June 2020, adopted an instruction regarding the appointment of the Nomination…

November 19, 2020

Lipidor publishes interim report for Q3 2020

STOCKHOLM, 19 August 2020: Today, Lipidor AB publishes its interim report for the period July – September 2020. The quarterly report is…

October 1, 2020

Lipidor strengthens management through strategic hire

Stockholm, 1 October 2020: Lipidor AB (Nasdaq First North: LIPI) today announces that the company is strengthening its management team through the…

September 30, 2020

Lipidor announces positive outcome of feasibility study for development of topical medical cannabis products based on the company’s AKVANO® technology

Stockholm, 30 September 2020 – Lipidor AB (Nasdaq First North:LIPI) today announces a positive outcome of the feasibility study into the development…

August 18, 2020

Correction: Lipidor publishes interim report for H1 2020

In the last press release, Lipidor published that the information and interim report was such that Lipidor is required to publish under…

August 18, 2020

Lipidor publishes interim report for H1 2020

Today, Lipidor AB publishes its interim report for the period January – June 2020. The quarterly report is available on the company's…

August 11, 2020

Resolutions from Lipidor’s Extraordinary General Meeting

Today, 11 August 2020, Lipidor AB (publ) (the “Company” or “Lipidor”) held an extraordinary general meeting (“EGM”) in Solna, Sweden. The EGM…

July 7, 2020

Lipidor signs agreement with CRO for implementation of Phase III clinical study of drug candidate AKP-02 against Psoriasis

Lipidor AB (Nasdaq First North: LIPI) today announced an agreement with Cadila Pharmaceuticals, a leading Indian pharmaceutical company with extensive CRO capacity,…